(Bloomberg) -- The following is a list of companies
whose shares are having unusual price changes on U.S. exchanges.
Stock symbols are in parentheses after company names. Shares
prices are as of 10:10 a.m. New York time.
Actelion Ltd. (ALIOF US) shares rose $3.74, or 8.8 percent,
to $46.45. A newly approved rival to its best-selling Tracleer
lung treatment may not be as big a threat as previously thought,
some analysts said. Gilead Sciences Inc. (GILD US) on June 15 won
U.S. approval for ambrisentan, which will compete with Tracleer
as a treatment for pulmonary arterial hypertension, a narrowing
of the arteries that causes shortness of breath and heart
failure. Gilead lost 44 cents to $80.39.
Read more at Bloomberg Stocks News
whose shares are having unusual price changes on U.S. exchanges.
Stock symbols are in parentheses after company names. Shares
prices are as of 10:10 a.m. New York time.
Actelion Ltd. (ALIOF US) shares rose $3.74, or 8.8 percent,
to $46.45. A newly approved rival to its best-selling Tracleer
lung treatment may not be as big a threat as previously thought,
some analysts said. Gilead Sciences Inc. (GILD US) on June 15 won
U.S. approval for ambrisentan, which will compete with Tracleer
as a treatment for pulmonary arterial hypertension, a narrowing
of the arteries that causes shortness of breath and heart
failure. Gilead lost 44 cents to $80.39.
Read more at Bloomberg Stocks News
No comments:
Post a Comment